financetom
Business
financetom
/
Business
/
Conagra Brands Posts Lower-Than-Projected Results, Affirms Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Conagra Brands Posts Lower-Than-Projected Results, Affirms Guidance
Apr 3, 2025 7:58 AM

10:42 AM EDT, 04/03/2025 (MT Newswires) -- Conagra Brands ( CAG ) on Thursday reported weaker-than-anticipated fiscal third-quarter results, while the packaged food company left its full-year outlook intact amid an evolving economic environment.

Adjusted earnings dropped to $0.51 per share for the three months ended Feb. 23 from $0.69 a year earlier and missed the average analyst estimate of $0.52 on FactSet. Net sales declined 6.3% to $2.84 billion, below the consensus for $2.90 billion.

The parent of frozen food brands Birds Eye and Healthy Choice reported a 5.2% decrease in organic sales, reflecting a 2.1% price/mix headwind and a 3.1% decrease in volume. By segment, grocery and snacks revenue decreased 3.2% to $1.2 billion, while the refrigerated and frozen division fell 7.2% to $1.1 billion. Foodservice sales also declined.

"Shipments lagged behind consumption during the third quarter, in part due to the discrete supply constraints we announced in mid-February," Chief Executive Sean Connolly said in pre-recorded remarks ahead of an earnings call Thursday. "We experienced supply challenges in two product platforms -- frozen meals containing chicken and frozen vegetables - which prevented us from fully servicing demand during the quarter."

For fiscal 2025, the company continues to expect adjusted EPS about $2.35 per share, with organic net sales anticipated to decline nearly 2%. Analysts are looking for $2.35 on revenue of $11.74 billion, which indicated a decline year over year.

Fourth-quarter volume is expected to increase sequentially, while shipments should improve "as we restock retailer inventories in supply constrained areas," Chief Financial Officer David Marberger said in prepared remarks.

"Our fiscal 2025 guidance remains unchanged as we continue to closely monitor the dynamic external environment, including tariffs and trade impacts, regulatory and policy changes, inflation, and shifts in consumer sentiment," Connolly said. "Amid this evolving landscape, we remain focused on strong execution and operating with agility to drive sustainable success."

In a statement on Thursday, the company said it anticipates "limited impact to fiscal 2025 from previously announced US tariffs on steel and aluminum and imports from China." The guidance does not reflect other tariffs.

President Donald Trump on Wednesday announced sweeping new tariffs, targeting imports from several countries including China and Japan.

Price: 26.83, Change: +0.45, Percent Change: +1.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NYSE's Vitesse Energy Buying Lucero Energy in Accretive All-Stock Deal
NYSE's Vitesse Energy Buying Lucero Energy in Accretive All-Stock Deal
Dec 16, 2024
07:53 AM EST, 12/16/2024 (MT Newswires) -- Vitesse Energy entered Monday into a definitive agreement to acquire Lucero Energy ( PSHIF ) in an all-stock transaction with a fully diluted equity value of US$222 million. Each outstanding common share of Lucero will be exchanged for 0.01239 of a share of Vitesse common stock, with approximately 8,175,000 shares of common stock...
Foghorn Therapeutics Discontinues Development of FHD-286 Clinical Program; Shares Fall Pre-Bell
Foghorn Therapeutics Discontinues Development of FHD-286 Clinical Program; Shares Fall Pre-Bell
Dec 16, 2024
07:50 AM EST, 12/16/2024 (MT Newswires) -- Foghorn Therapeutics ( FHTX ) said Monday it has decided to discontinue the independent development of FHD-286 in combination with decitabine to treat patients with relapsed and/or refractory acute myeloid leukemia. The company is evaluating collaborations and investigator sponsored trials for advancing FHD-286, it said, adding that it will now prioritize investment in...
Leading Edge Materials Gives Outlook on Swedish, Romanian Operations
Leading Edge Materials Gives Outlook on Swedish, Romanian Operations
Dec 16, 2024
07:46 AM EST, 12/16/2024 (MT Newswires) -- Leading Edge Materials ( LEMIF ) on Monday provided an outlook for its operations in Sweden and Romania. The company has applied to the Swedish authorities for a 25-year mining lease for its Norra Karr Heavy Rare Earth (HREE) Project, said CEO Kurt Budge. The permit is expected in the second quarter of...
Top Premarket Decliners
Top Premarket Decliners
Dec 16, 2024
07:51 AM EST, 12/16/2024 (MT Newswires) -- SOBR Safe ( SOBR ) shares slumped 34% pre-bell Monday, extending Friday's slide. Zoomcar Holdings ( ZCAR ) shares fell 27% following a muted session. Cullinan Therapeutics ( CGEM ) shares retreated 23% following a 3.7% drop in the previous session. Lensar ( LNSR ) shares decreased almost 20% after Friday's 2.1% loss....
Copyright 2023-2026 - www.financetom.com All Rights Reserved